Kinetic Concepts to sell NeutroPhase solution:
This article was originally published in Clinica
Executive Summary
Kinetic Concepts (San Antonio) has secured exclusive worldwide rights to commercialise a wound disinfectant developed by Novabay Pharmaceuticals. NeutroPhase is a diluted solution of hypochlorous acid in saline with broad-spectrum antimicrobial properties, developed to kill a wide range of bacteria. The company claim that the solution has been shown not to harm cells, and is rapidly effective against common wound pathogens at concentrations that are 200 times lower than the level toxic to human cells. Kinetic plans to market NeutroPhase as a stand alone product for cleansing wounds, and also in combination with its own proprietary VAC (Vacuum-Assisted Closure) Instill wound-healing therapy.